NYLIM
PATH icon

New York Life Investment Management’s UiPath PATH Stock Holding History

New York Life Investment Management’s Portfolio PATH Stock Details PATH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-49,583
Closed -$550K – 811
2026
Q1 		$550K Buy
49,583
+12,429
+33% +$158K ﹤0.01% 748
2025
Q4 		$609K Sell
37,154
-4,085
-10% -$63.6K 0.01% 696
2025
Q3 		$552K Sell
41,239
-3,917
-9% -$46.3K ﹤0.01% 765
2025
Q2 		$578K Sell
45,156
-252
-0.6% -$3.02K 0.01% 747
2025
Q1 		$468K Buy
45,408
+270
+0.6% +$3.48K ﹤0.01% 784
2024
Q4 		$574K Sell
45,138
-5,113
-10% -$67.6K 0.01% 771
2024
Q3 		$643K Buy
50,251
+2,831
+6% +$34.7K 0.01% 790
2024
Q2 		$601K Buy
47,420
+2,491
+6% +$43.1K 0.01% 787
2024
Q1 		$1.02M Buy
44,929
+666
+2% +$15.6K 0.01% 668
2023
Q4 		$1.1M Buy
+44,263
New +$864K 0.01% 638

Other funds holding PATH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

New York Life Investment Management's PATH Position: Q2 2026 in Review

New York Life Investment Management sold out of UiPath (PATH) in Q2 2026, closing a stake of 49,583 shares — an estimated $550K sold.

New York Life Investment Management first reported a position in PATH in Q4 2023 and held it in 10 quarters. The position peaked at $1.1M in Q4 2023. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • New York Life Investment Management reported no remaining UiPath position as of Q2 2026 after selling out during the quarter.
  • New York Life Investment Management sold 49,583 UiPath shares in Q2 2026, an estimated $550K.
  • New York Life Investment Management first reported a position in UiPath in Q4 2023 and held it in 10 quarters.
  • New York Life Investment Management's UiPath position peaked at $1.1M in Q4 2023.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.